Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 10/5/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 10/5/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +1.36% | +3.06% | +12.67% | +84.59% | 55.53B | |
| +1.51% | +1.53% | +12.77% | +104.75% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| -1.95% | +43.22% | +104.46% | +90.91% | 34.47B | |
| -2.72% | -0.44% | +23.18% | -10.77% | 24.23B | |
| Average | +0.56% | +4.08% | +52.38% | +162.64% | 43.62B | |
| Weighted average by Cap. | +0.88% | +3.49% | +49.41% | +160.58% |
Employees
457
